Star Stocks lead the recovery

Presented by
Mathew Potts

Mathew Potts

Member Relationship Manager - Stock Doctor

Apr 29th, 2020
1hr 29mins

Over the last few weeks, we have seen a flattening of the global COVID-19 curve with increasing optimism that restrictions could be lifted sooner than expected.

Coupled with substantial monetary and fiscal stimulus, the market has rebounded strongly with our portfolio of Star Stock recommendations leading the way.

In this webinar recording, Mathew Potts, Business Development Manager, will share insights on the Stock Doctor methodology and how it can be used to protect your portfolio during an economic recession.

Our Lincoln Australian Growth Fund has been using Stock Doctor to be one of Australia’s leading Fund Managers in its category, ranked in the top quartile over the last five years and outperforming the market by 7.8% last month.

Mathew is joined by Equities Analyst, Jason Yin, to showcase a live demonstration of how Stock Doctor can arm you with the research, stock recommendations, tools, education and support you need in this volatile market period.

In this webinar recording we discuss:

  • Using our academically proven Financial Health Model to identify the stocks to avoid and those at risk of complete failure like Virgin Australia.
  • Identifying investment opportunities with our Star Stock recommendations.
  • Proactively managing your portfolio with Stock Doctor’s essential toolset and one of our four proven strategies, based on your tolerance and sensitivity to share market volatility.
  • U.S. Growth Fund performance and launch update.
Presented by
Mathew Potts

Mathew Potts

Member Relationship Manager - Stock Doctor

Apr 29th, 2020
1hr 29mins
Information in this communication is current as of publication unless otherwise stated. It is provided for educational purposes only and may not reflect current market data or opinion. It should not be relied upon in respect to any current investment decision. Investments can go up and down. Past performance is not a reliable indicator of future performance.

Important: This communication is provided by or on behalf of Lincoln Indicators Pty Limited ABN 23 006 715 573 (Lincoln), as Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167 for information and educational purposes only. This content may contain general financial product advice. It has been prepared without taking account of your personal circumstances and you should therefore consider its appropriateness in light of your objectives, financial situation and needs, before acting on it. Investments can go up and down. Past performance is not a reliable indicator of future performance. Shares and other investments may go up and down in value, and their past performance may not be repeated and gives no guarantee of future performance. Information in this communication was current as at the date of its preparation, unless otherwise stated, and may be subject to change.

You should read and consider our Important Information and our Financial Services Guide (FSG) which sets out key information about the services we provide. Where our advice relates to the acquisition or possible acquisition of a particular financial product, you should obtain a copy of and consider the Lincoln Australian Income Fund Product Disclosure Statement (PDS), Lincoln Australian Growth Fund Product Disclosure Statement (PDS) and Lincoln U.S. Growth Fund Product Disclosure Statement (PDS) for the product at www.lincolnindicators.com.au before making any decision.

At the date of preparation of this communication, Lincoln, Lincoln Financial Group Pty Ltd or directors, employees and/or associates of these entities "may hold" interests in these ASX-listed companies. Further information about particular stocks held by these entities or persons from time to time is disclosed within the Stock Doctor program and may change at any time without notice.

Lincoln, Lincoln Financial Group Pty Ltd, any directors, employees and agents of these entities, make no representation and give no warranty as to the accuracy of this communication and do not accept any responsibility for any errors or inaccuracies in, or omissions from, this communication (whether negligent or otherwise) and are not liable for any loss or damage howsoever arising as a result of any person acting, or refraining from acting, in reliance on any information in this communication. No person should rely on this communication as it does not purport to be comprehensive. This disclaimer does not purport to exclude any rights under, or warranties implied by, law which may not be lawfully excluded.

Lincoln has taken precautions to minimise the risk of transmitting software viruses, but we advise you to carry out your own virus checks on any downloadable content. We do not accept liability for any loss or damage caused by software viruses.

Copyright © 2024 Lincoln Indicators Pty Ltd. All rights reserved.

All financial services are provided by Lincoln Indicators Pty Ltd ABN 23 006 715 573 (Lincoln) as the Corporate Authorised Representative of Lincoln Financial Group Pty Ltd ABN 70 609 751 966, AFSL 483167.

  • Show Popular Searches
  • Lincoln Indicators
  • Managed Funds
  • Investment Funds
  • Mutual Funds
  • Growth Funds
  • High Return Investments
  • Long Term Investments
  • Shares to Invest in Australia
  • Stock Portfolio Manager Software
  • Highest Dividend Stocks ASX
  • Highest Dividend Shares
  • Growth Stocks
  • ASX Stocks to Buy
  • Stock Research Reports
  • ASX Research Reports
  • Equity Funds
  • Hide Popular Searches